Johnson and Johnson asked to cut down price of new TB drug

​​ To ensure the drug is accessible to all, MSF called on J&J to issue a non-exclusive license to the Medicines Patent Pool to allow for price-lowering competition among generic producers.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2EH56iq
via IFTTT